Acquisition by Rocamboli Stephen of 3165 shares of Tff Pharmaceuticals subject to Rule 16b-3
| TFFP Stock | USD 0.34 0.03 9.68% |
Slightly above 69 percent of all Tff Pharmaceuticals' retail investors are curious in acquiring. The analysis of overall sentiment of trading Tff Pharmaceuticals stock suggests that quite a few investors are confidant at this time. Tff Pharmaceuticals' investing sentiment overview a quick insight into current market opportunities from investing in Tff Pharmaceuticals. Many technical investors use Tff Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Tff |
Filed transaction by Tff Pharmaceuticals Director. Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
Cash Flow Correlation
Tff Pharmaceuticals' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Tff Pharmaceuticals' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Tff Pharmaceuticals Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Tff Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Tff Pharmaceuticals Fundamental Analysis
We analyze Tff Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tff Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tff Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Tff Pharmaceuticals is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Tff Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Tff Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Tff Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Tff Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Tff Pharmaceuticals Related Equities
| PASG | Passage Bio | 68.66 | ||||
| LYEL | Lyell Immunopharma | 3.26 | ||||
| CNTB | Connect Biopharma | 2.91 | ||||
| DSGN | Design Therapeutics | 0.50 | ||||
| FOLD | Amicus Therapeutics | 0.20 | ||||
| ORIC | Oric Pharmaceuticals | 0.70 | ||||
| CRNX | Crinetics Pharmaceuticals | 0.81 | ||||
| LGND | Ligand Pharmaceuticals | 0.88 | ||||
| RVMD | Revolution Medicines | 1.25 | ||||
| ENTA | Enanta Pharmaceuticals | 2.60 |
Additional Tools for Tff Stock Analysis
When running Tff Pharmaceuticals' price analysis, check to measure Tff Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tff Pharmaceuticals is operating at the current time. Most of Tff Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tff Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tff Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tff Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.